Bartlett & Co. Wealth Management LLC Embecta Corp. Transaction History

Bartlett & Co. Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$12.35 - $19.33 $3,470 - $5,431	-281 Reduced 83.14%	57 $756,000
Q4 2023 Feb 14, 2024	SELL	$12.87 - $19.09 $1,544 - $2,290	-120 Reduced 26.2%	338 $6.45 Million
Q3 2023 Feb 14, 2024	SELL	$15.0 - $22.17 $195 - $288	-13 Reduced 2.76%	458 $6.89 Million
Q2 2023 Feb 14, 2024	BUY	$21.6 - $30.69 $1,425 - $2,025	66 Added 16.3%	471 $10.2 Million
Q1 2023 Feb 14, 2024	SELL	$23.07 - $32.77 $12,550 - $17,826	-544 Reduced 57.32%	405 $11.4 Million
Q4 2022 Feb 14, 2024	SELL	$25.29 - $35.48 $11,785 - $16,533	-466 Reduced 32.93%	949 $24.1 Million
Q3 2022 Feb 14, 2024	SELL	$24.0 - $33.42 $19,488 - $27,137	-812 Reduced 36.46%	1,415 $40.7 Million
Q2 2022 Feb 14, 2024	BUY	$24.78 - $33.36 $55,185 - $74,292	2,227 New	2,227 $56.4 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.